Osteoporosis Fracture Clinical Trial
Official title:
Development and Validation of a Postoperative Re-fracture Risk Model for Osteoporotic Spinal Fractures: a Multicenter Prospective Cohort Study
In this project, IDEAL-IQ technology and PDFF and R2* image-based imaging methods are used to analyze the intrinsic relationship between preoperative vertebral bone marrow fat content, magnetic susceptibility properties of bone tissue and bone strength (bone volume and bone mass), to explore the mechanism of vertebral re-fracture after PVP / PKP, and to explore the imaging markers for the risk of postoperative vertebral re-fracture after PVP / PKP. To construct a precise and individualized risk assessment model of vertebral re-fracture after PVP/ PKP by combining clinical risk factors, preoperative quantitative MRI parameters (PDFF, R2*) and imaging characteristics, so as to achieve the goal of objectively and accurately evaluating the risk of vertebral re-fracture at the early stage of the postoperative period (1 year).
Status | Recruiting |
Enrollment | 560 |
Est. completion date | December 31, 2027 |
Est. primary completion date | December 31, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 50 Years to 90 Years |
Eligibility | Inclusion Criteria: - Patients diagnosed with osteoporotic vertebral fractures of the thoracic and lumbar level with reference to the 2022 edition of the Osteoporotic Fractures Guidelines (2022 edition); - The presence of bone marrow edema or hemorrhage (acute fracture) in the fractured vertebrae is clearly defined by MR examination, and the responsible vertebrae is treated with PVP / PKP; - Number of fractured vertebrae: 1-3 vertebral compression fractures (including old fractures). Exclusion Criteria: - History of severe scoliosis, vertebroplasty, or internal spinal fixation; - Presence of spinal infection and malignant neoplastic disease; - Presence of mental disease, cognitive impairment, or critical illness (e.g., severe cardiac or cerebrovascular disease). |
Country | Name | City | State |
---|---|---|---|
China | The Seventh Affiliated Hospital, Sun Yat-sen University | Guangzhou | Guangdong |
Lead Sponsor | Collaborator |
---|---|
The Seventh Affiliated Hospital of Sun Yat-sen University | Dongguan Hospital of Traditional Chinese Medicine, Huizhou Municipal Central Hospital, The Fourth Affiliated Hospital of Guangzhou Medical University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Non-operative vertebral re-fracture within 1 year after PVP / PKP | Non-operative vertebral re-fracture within 1 year after PVP / PKP, confirmed by follow-up spinal MRI | 1 year | |
Secondary | Visual Analog Score (VAS) at 1 year after PVP/ PKP | Visual Analog Score (VAS) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review. | 1 year | |
Secondary | Oswestry Dysfunction Index (ODI) at 1 year after PVP/PKP | Oswestry Dysfunction Index (ODI) at 1 year after PVP / PKP were obtained by completing the appropriate questionnaires on-site at the time of the 1-year postoperative spinal MRI review. | 1 year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06024148 -
Continuation of Anti-osteoporotic Treatment 1 Year After Initial Administration
|
||
Completed |
NCT03710889 -
Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
|
Phase 3 | |
Recruiting |
NCT05058976 -
Romosozumab Use to Build Skeletal Integrity
|
Phase 4 | |
Completed |
NCT03798444 -
Height Loss, Kyphosis Indicators, Bone Mineral Density and Vertebral Fractures in Chinese Postmenopausal Women
|
||
Completed |
NCT04960033 -
Evaluating Fracture Risk Assessment Tools (FRAX) From Different Regions in Central South Chinese Postmenopausal Women
|
||
Completed |
NCT05366621 -
Post-fracture Medication and Mortality
|
||
Not yet recruiting |
NCT04597931 -
Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density
|
Phase 4 | |
Completed |
NCT02483286 -
Osteoporosis and Fall Prevention With Multiple Interventions in the Metropolitan Area
|
N/A | |
Enrolling by invitation |
NCT03178799 -
Randomized Fracture Liaison Services
|
||
Completed |
NCT02803190 -
Osteoporosis and Fall Prevention and Posture Correction Interventions in the Metropolitan Area
|
N/A | |
Recruiting |
NCT03451305 -
Postrual Reduction With Pillow in Osteoporotic Vertebral Fracture
|
N/A | |
Recruiting |
NCT03811509 -
Breast Cancer Women on Aromatase Inhibitors Treatment
|
Phase 4 |